Mansour S Al-Moundhri Selected Research

E2F5 Transcription Factor

7/2017

Molecular genetics complexity impeding research progress in breast and ovarian cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mansour S Al-Moundhri Research Topics

Disease

6	Stomach Neoplasms (Stomach Cancer) 07/2010 - 01/2006
5	Neoplasms (Cancer) 02/2021 - 07/2008
3	Breast Neoplasms (Breast Cancer) 01/2016 - 07/2008
2	Lymphoma (Lymphomas) 11/2014 - 07/2008
1	Infections 02/2021
1	Triple Negative Breast Neoplasms 07/2017
1	Ovarian Neoplasms (Ovarian Cancer) 07/2017
1	Ovarian Epithelial Carcinoma 07/2017
1	Neoplasm Metastasis (Metastasis) 12/2009
1	Tuberous Sclerosis (Bourneville's Disease) 04/2009
1	Head and Neck Neoplasms (Head and Neck Cancer) 07/2008
1	Hepatocellular Carcinoma (Hepatoma) 07/2008
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2008
1	Adenocarcinoma 07/2008
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2008
1	Renal Cell Carcinoma (Grawitz Tumor) 07/2008
1	Colonic Neoplasms (Colon Cancer) 07/2008
1	Glioblastoma (Glioblastoma Multiforme) 07/2008
1	Hypercalcemia (Milk Alkali Syndrome) 12/2007
1	Sjogren's Syndrome (Sjogren Syndrome) 12/2006
1	Disease Progression 12/2006
1	Carcinogenesis 01/2006

Drug/Important Bio-Agent (IBA)

5	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 01/2006
3	SultanIBA 02/2021 - 12/2007
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 02/2009 - 01/2006
1	E2F5 Transcription FactorIBA 07/2017
1	Biomarkers (Surrogate Marker)IBA 07/2017
1	Biological ProductsIBA 07/2017
1	ChromatinIBA 07/2017
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Docetaxel (Taxotere)FDA Link 01/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	Small Untranslated RNAIBA 01/2016
1	Adenine FDA LinkGeneric 01/2012
1	Insulin-Like PeptidesIBA 01/2012
1	CytosineIBA 01/2012
1	Cadherins (E-Cadherin)IBA 07/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2009
1	Tuberous Sclerosis Complex 1 ProteinIBA 04/2009
1	Tuberous Sclerosis Complex 2 ProteinIBA 04/2009
1	Proteins (Proteins, Gene)FDA Link 04/2009
1	glutathione S-transferase M1IBA 02/2009
1	Glutathione Transferase (Glutathione S-Transferase)IBA 02/2009
1	InterleukinsIBA 02/2009
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2008
1	Bevacizumab (Avastin)FDA Link 07/2008
1	Dasatinib (BMS 354825)FDA Link 07/2008
1	Cetuximab (Erbitux)FDA Link 07/2008
1	Imatinib Mesylate (Gleevec)FDA Link 07/2008
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2008
1	Rituximab (Mabthera)FDA Link 07/2008
1	Trastuzumab (Herceptin)FDA Link 07/2008
1	Monoclonal AntibodiesIBA 07/2008
1	Tyrosine Kinase InhibitorsIBA 07/2008
1	Panitumumab (Vectibix)FDA Link 07/2008
1	Lapatinib (GW572016)FDA Link 07/2008
1	Sunitinib (Sutent)FDA Link 07/2008
1	Sorafenib (BAY 43-9006)FDA Link 07/2008
1	temsirolimus FDA Link 07/2008
1	AcetyltransferasesIBA 05/2007
1	AntibodiesIBA 12/2006
1	RibonucleoproteinsIBA 12/2006
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 12/2006
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 12/2006
1	Reticulin (Reticular Fiber)IBA 12/2006
1	Peroxidase (Myeloperoxidase)IBA 12/2006
1	Myeloblastin (Proteinase 3)IBA 12/2006
1	Histidine-tRNA LigaseIBA 12/2006
1	AutoantibodiesIBA 12/2006
1	AntigensIBA 12/2006
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2006
1	CytokinesIBA 01/2006

Therapy/Procedure

2	Vascular Access Devices (Arterial Line) 02/2021 - 11/2014
2	Therapeutics 07/2017 - 07/2008
2	Adjuvant Chemotherapy 01/2016 - 07/2008
1	Central Venous Catheters 11/2014
1	Drug Therapy (Chemotherapy) 07/2008